The RET proto-oncogene encodes a Tyrosine Kinase Receptor (RTK) which plays an important function in the proliferation and/or dierentiation of neuroectodermic cells. Germline mutation of a methionine to a threonine within the RET TK domain predisposes to the Multiple Endocrine Neoplasia type 2B (MEN 2B). It has been demonstrated that, unlike c-Ret, the MEN 2B mutated Ret displays constitutive TK activity, tyrosine autophosphorylation and transforms ®broblasts. However, this oncoprotein is more than a fully activated wildtype (WT) Ret TK since it also displays modi®ed substrate speci®city. Change in substrate speci®city leads to the tyrosine autophosphorylation of MEN 2B Ret on new sites as well as the phosphorylation of several novel downstream targets. But, none of these substrates have been identi®ed and the ability of MEN 2B Ret phosphoprotein to interact with Src Homology 2 (SH 2 ) domain containing molecules has been poorly investigated. In this report, using a constitutively activated Ret TK form, Ret-ptc 2, we demonstrate that the MEN 2B as the activated WT Ret TK binds to several SH 2 signalling proteins such as Shc, Grb-2, Phospholipase Cg, Crk and Nck. However, in contrast to the activated WT form, expression of the MEN 2B mutated Ret-ptc 2 results in the tyrosine phosphorylation of a panel of proteins which interestingly interact with Crk and Nck. We identi®ed Paxillin, a cytoskeletal protein as one of the Crk associated proteins that is dramatically phosphorylated in MEN 2B but not in WT Ret expressing cells. These data suggest that MEN 2B mutated Ret triggers distinct signalling pathways that might be related to its transforming power.
Introduction
The RET proto-oncogene encodes a Tyrosine Kinase Receptor (RTK), likely involved in the control of proliferation, migration and/or dierentiation of neural crest cells (Takahashi et al., 1988 (Takahashi et al., , 1989 . Very recently, it has been demonstrated that the biological activities of Glial cell line-Derived Neurotrophic Factor (GDNF) are mediated by the activation of Ret TK, suggesting that it corresponds to its ligand (Durbec et al., 1996; Sanchez et al., 1996; Trupp et al., 1996) . However, a glycolipid-anchored membrane protein, called GDNFR-a, was identi®ed as the true GDNF binding component. It has been proposed that GDNFR-a binds GDNF and then the complex activates the Ret TK (Treanor et al., 1996) . Dierent oncogenic forms of RET have been implicated in several human cancers such as Papillary Thyroid Carcinomas (PTC) (Bongarzone et al., 1993 (Bongarzone et al., , 1994 Santoro et al., 1994a) , Multiple Endocrine Neoplasia type 2A and 2B (MEN 2A and 2B) and Familial Medullary Carcinoma (FMTC) (Carlson et al., 1994; Donis-Keller et al., 1993; Hofstra et al., 1994; Mulligan et al., 1993 Mulligan et al., , 1994 . These oncogenes encode, unlike c-RET, phosphorylated proteins with constitutive TK activity. As a consequence of TK activity, transfection of these oncogenes transforms ®broblasts and induces the dierentiation of PC12 cells Pasini et al., 1995) . However, in these cancers, dierent mechanisms lead to a gain of function of Ret. In PTC, at least four somatic rearrangements cause the fusion of the cytoplasmic RET TK sequence downstream of a portion of unrelated donor genes (Bongarzone et al., 1993 (Bongarzone et al., , 1994 Fugazzola et al., 1996; Grieco et al., 1990; Santoro et al., 1994a) . The resulting oncogenes encode cytosolic chimeric proteins, Ret-ptc, in which the N-terminal portion mediates the dimerization. In contrast, both FMTC and MEN 2A are due to germline point mutations of one of the ®ve cysteine residues present in the Ret extracellular domain, that are involved in intramolecular disul®de bonds (Carlson et al., 1994; Donis-Keller et al., 1993; Hofstra et al., 1994; Mulligan et al., 1993 Mulligan et al., , 1994 . Consequently, these substitutions leave one cysteine available to form a disul®de bond between two mutated Ret molecules (Asai et al., 1995; Santoro et al., 1995) . Therefore, the common feature of the Ret-ptc, FMTC and MEN 2A mutated molecules is the permanent Ret TK dimerization, resulting in the constitutive TK activity. Since these oncoproteins carry an activated wild-type (WT) Ret TK domain, it is tempting to hypothesize that they may share the same substrate speci®city and hence the same signalling pathway. On the contrary, a single Met
918
?Thr substitution within the TK domain predisposes to MEN 2B through a mechanism that does not imply Ret TK dimerization, but rather alters its substrate speci®city to that observed among cytosolic Src-like kinases (Santoro et al., 1995; Songyang et al., 1995) . Change in substrate speci®city leads to the tyrosine autophosphorylation of MEN 2B Ret on new sites as well as the phosphorylation of novel downstream targets. However, none of these substrates have been identi®ed and the ability of MEN 2B Ret phosphoprotein to interact with Src Homology 2 (SH 2 ) domain containing molecules has been reported only for Shc . Moreover, the tyrosine residues which are essential for the MEN 2A or the MEN 2B transforming activity are dierent . Hence, the MEN 2B mutated Ret may induce malignant transformation through the activation of distinct but still unidenti®ed pathway(s).
The aim of this study was to characterize the early transduction pathway mediated by the MEN 2B mutated Ret TK. Using a constitutively activated Ret TK form, Ret-ptc 2, we have shown that several SH 2 containing cellular transducers, such as Shc, Grb-2, Phospholipase Cg(PLCg), Crk and Nck, interact with MEN 2B mutated Ret-ptc 2. All these molecules also associate with the WT Ret-ptc 2, suggesting that the WT and MEN 2B mutated Ret share at least several cytosolic eectors. However, the expression of MEN 2B Ret-ptc 2 allows the phosphorylation of a panel of cellular proteins that are not present in the WT Ret-ptc 2 expressing cells. Interestingly, this set of substrates interact specifically with Crk and Nck. We identi®ed Paxillin, a cytoskeletal protein as one of the Crk associated proteins that is dramatically phosphorylated in MEN 2B but not in WT Ret-ptc 2 expressing cells. These data shed some light on the mechanisms by which the MEN 2B mutated form of Ret could lead to cellular transformation. , 1995) . As shown in Figure 1a , when lysates from transfected and untransfected COS cells were immunoprecipitated with a speci®c antibody against Ret followed by immunoblotting with the same antiserum (a Ret), all the transfected COS cells expressed correctly p76 Ret-ptc 2 and another band of a slightly higher molecular weight (*84 kDa). As previously described and discussed, this band was most likely due to an in frame additional ATG present in the pRc/CMV vector upstream of the coding sequence of RET-PTC 2 . As expected, these two Ret reactive proteins were not observed in untransfected control cells (lane 1). When the extent of phosphorylation was assessed by reprobing the same Western blot with anti-phosphotyrosine (a Ptyr) antibodies, the H13 chimeric protein (lane 4) was barely phosphorylated (detected after a longer exposure of the blot, data not shown), while WT, P18 and 2B proteins displayed a high phosphorylation level (lanes 2, 3 and 5, respectively). The a Ret immunoprecipitates from 2B but not from WT, P18 and H13 cell lysates contained three additional tyrosine phosphorylated proteins of 66, 52 and 46 kDa. In addition, the total protein tyrosine phosphorylation pattern in H13 COS cell lysates (Figure 1 Crk adaptor binds a distinct set of phosphoproteins in WT and MEN 2B Ret-ptc 2 expressing cells It is well established that receptor autophosphorylation creates multiple binding sites for SH 2 domain containing proteins within the kinase domain of RTK . To investigate whether the MEN 2B mutation modi®es Ret signalling, we compared the ability of the WT and MEN 2B mutated Ret-ptc 2 to bind SH 2 transducing molecules such as Shc, Grb-2, PLCg, Crk and Nck. In this purpose, lysates from WT, H13, 2B RET-PTC 2 transfected and untransfected cells were either precipitated (P) with Glutathione S-Transferase (GST) fusion proteins (Shc, Grb-2, PLCg, Crk and Nck-GST proteins) or immunoprecipitated (Ip) with antibodies raised against this set of transduction proteins. After separation, the precipitated proteins were analysed by Western blot using either a Ret or a Ptyr antibodies. We ®rst found that Shc, Grb-2 and PLCg which are known to interact with WT Ret Borrello et al., 1994 Borrello et al., , 1996 Santoro et al., 1994b) , interacted also with the MEN 2B mutated Ret-ptc 2 (data not shown).
Results

Expression
Crk is an adaptor consisting of SH 2 and SH 3 domains, which can bind simultaneously to tyrosine phosphorylated proteins via SH 2 domains and to proline-rich signalling molecules through its SH 3 domain. It is implicated in signal transduction of dierent TKs (Hempstead et al., 1994; Mayer and Hanafusa, 1990; Mayer et al., 1991; , but its involvement in the Ret signalling pathway has never been investigated. As shown in Figure 2 , WT and MEN 2B Ret-ptc 2 proteins were precipitated in vitro by the full-length Crk GST fusion protein. Accordingly, the analysis in intact cells demonstrated that Crk interacted equally with the WT and MEN 2B Ret-ptc 2 proteins and to a lesser level, with the H13 mutated form. When the blot was reprobed with a Ptyr antibodies, p42
Crk was tyrosine phosphorylated in WT and MEN 2B Ret-ptc 2 expressing cells. In addition, the pattern of the phosphorylated proteins that were coprecipitated with Crk, was more complex in cells expressing the MEN 2B than the WT Ret-ptc 2. Indeed, Crk coimmunoprecipitated with phosphoproteins presenting an apparent molecular weight of *50 ± 52, 62, 66, 68 and 200 kDa, that were not detectable in the Crk Lysates from untransfected and WT, H13, 2B RET-PTC 2 transfected COS cells were subjected to precipitation (P) with the full-length Crk GST fusion protein or to immunoprecipitation (Ip) with the a Crk (Transduction Laboratories or Santa Cruz Biotechnologies) antibodies. Crk expression as well as coprecipitations of Ret-ptc 2 and tyrosine phosphorylated proteins were analysed by sequentially probing the same Western blots with a Crk (data not shown), a Ret and biotin conjugated a Ptyr antibodies (results obtained with P18 lysates were identical to WT and were not shown). Open and closed arrowheads represent the two isoforms of Ret-ptc 2 and the phosphorylated proteins, respectively immunopellets from WT RET-PTC 2 transfected cells.
Crk SH 2 domain mediates the interaction between Crk and the phosphoproteins
To further delineate which domain of Crk was involved in the recruitment of these phosphoproteins, recombinant GST fusion molecules encompassing either the Crk SH 2 or SH 3 domain were used to precipitate phosphoproteins from lysates of transfected and untransfected COS cells. The a Ptyr immunoblotting analysis of these precipitates, presented in Figure  3 , shows that the Crk SH 3 GST (lanes 13 ± 16) domain as well as the control GST protein (data not shown) did not bind any of the tyrosine phosphorylated proteins, suggesting that Crk interacted with these phosphoproteins only via its SH 2 domain. Accordingly, in the WT lysates, the Crk SH 2 domain precipitated two proteins of 76 and 84 kDa that were also observed in the a Crk immunoprecipitates.
In the 2B RET-PTC 2 transfected cells, four tyrosinephosphorylated proteins of *50 ± 52, 68, 76 and 84 kDa interacted with the Crk SH 2 fusion molecule. These four phosphoproteins was also observed in the a Crk immunoprecipitates from the 2B lysates, even though the protein separation between the 68 and 84 kDa was not optimal. Minor unidenti®ed tyrosinephosphorylated proteins with apparent molecular weight of 60, 120 and 200 kDa also clearly bound to Crk SH 2 domain (as revealed by long exposure of the Western blot, data not shown). In the purpose to identify which of the Crk-associated proteins directly interacted with its SH 2 domain, we subjected SDS denatured lysates to a precipitation procedure with the Crk SH 2 domain. Indeed, the recognition site for the SH 2 domains consists of a speci®c linear sequence containing tyrosine phosphorylated residues , that is maintained even after the denaturation of the protein three-dimensional structure. Under these conditions, the three major phosphoproteins p68, p76 and p84 were still detectable in the Crk SH 2 precipitates (lanes 9 ± 12) while p50 ± 52 phosphoprotein was lost, suggesting that it associated to the Crk SH 2 domain through a protein intermediate.
Expression of MEN 2B
Ret-ptc 2 leads to the tyrosine phosphorylation of Paxillin and its direct binding to the SH 2 domain of Crk
Consistent with the coimmunoprecipitation of Ret-ptc 2 with Crk, the p76 and p84 phosphoproteins that bound directly to the Crk SH 2 domains were identi®ed in WT and 2B lysates by a Ret reprobing, as the two phosphorylated forms of Ret-ptc 2, Figure 4a (upper panels). For the p68 phosphoprotein which binds directly to the Crk SH 2 domain, we suspected that it corresponds to Paxillin, a 68 ± 75 kDa cytoskeletal protein, that was shown to associate, on its tyrosine phosphorylated form with Crk in v-Crk transformed cells . To ascertain it, the same blot was reprobed with an a Paxillin monoclonal antibody. As shown in Figure 4a (lower panels), Paxillin was present in the Crk SH 2 precipitates from 2B (lanes 4 and 8) and at a barely detectable extent from WT lysates (lanes 2 and 6, only after overexposure of the blot) both under native and denaturing conditions. The comparison between the a Ptyr and a Paxillin immunoblots showed that the tyrosine-phosphorylated p68 protein comigrated exactly with Paxillin, strongly suggesting that they corresponded to the same entity (data not shown Similarly to Crk, Nck is a SH 2 /SH 3 molecular adaptor, the involvement of which has never been studied in the Ret signalling pathway. As shown in Figure 5 , Ret was present in the Nck immunoprecipitates from WT (lane 2), 2B (lane 4) and to a lesser extent, from the H13 (lane 3) transfected cells. When the same blot was reprobed with a Ptyr, there was a signi®cant dierence in the set of phosphoproteins coprecipitated by Nck in WT and 2B expressing cells. Indeed, at least eight phosphoproteins of respectively *50 ± 56, 63, 68, 130, 150 and 205 kDa were detected in a Nck immunopellets from 2B (lane 4) but not from the WT (lane 2) lysates. Most of these phosphoproteins were precipitated by the SH 2 domain of Nck from WT (lane 6) and 2B (lane 8) lysates. However, under denaturing conditions, only two (p76 and p84) or six (p63, p68, p72, p76, p84 and p130) proteins were present in WT (lane 10) and 2B (lane 12) precipitates respectively, thus suggesting a direct interaction between this panel of molecules and the SH 2 domain of Nck. When the same blots were reprobed with a Ret, the p76 and p84 phosphoproteins that bound directly to the Nck SH 2 domain were identi®ed in WT (lane 10) and 2B (lane 12) lysates as the two Ret-ptc 2 forms. Moreover, the Nck SH 3 domain was able to recruit in the 2B lysates several phosphoproteins exhibiting molecular weights ranging from 48 to 69 kDa and only minor tyrosinephosphorylated proteins of *120 and 185 kDa in 2B (lane 16), that were not detectable in WT (lane 14) lysates.
Discussion
The signalling pathways through which the MEN 2B mutated Ret TK induces cell malignant transformation are still not well de®ned. One of the earliest and obligatory biochemical steps which result in cellular transformation is the tyrosine phosphorylation of speci®c cellular proteins including the deregulated TK itself. Recently, it has been demonstrated that the WT and MEN 2B mutated Ret TK display dierent phosphorylation sites (Liu et al., 1996) . Since receptor autophosphorylation on tyrosine residues creates binding sites for SH 2 domain, one can thus hypothesize that the WT and MEN 2B Ret TK may recruit distinct subsets of SH 2 containing molecules. However, a comparative study on the ability of WT and MEN 2B Ret to interact with known SH 2 containing molecules has been reported only for Shc . We provide the ®rst evidence, both in vitro by using GST fusion proteins and in intact cells by coimmunoprecipitation, that Crk and Nck interacted directly with WT and MEN 2B Ret-ptc 2 through their SH 2 domains. It has been demonstrated by the use of peptide libraries that the SH 2 domain of Crk and Nck speci®cally bind to the pYXXP and pYDEP motifs, respectively (Songyang et al., 1993) . However, none of the 16 tyrosines present in the Ret TK domain match Results obtained with P18 lysates were identical to WT and were not shown these known recognition sequences, suggesting that novel docking sites for the SH 2 domain of Crk and Nck could be present in the WT and MEN 2B Ret. Therefore, since both MEN 2B and WT Ret-ptc 2 interact with Crk and Nck but also with Shc, Grb-2 and the PLCg (data not shown), it is likely that the MEN 2B mutated Ret TK shares, at least in part, common signalling pathways with the WT Ret. However, we found that the MEN 2B mutated Ret TK was more than a fully constitutive Ret TK, since it displayed distinct and novel properties. Indeed, compared with the WT lysates, several tyrosine phosphorylated proteins (of *42, 95, 120, 170, 205 ± 215 and 250 kDa) were speci®cally present in 2B RET-PTC 2 transfected cells, suggesting that the MEN 2B mutation introduced a qualitative modi®cation in the Ret TK substrate speci®city. Studies on RTK have elucidated the critical roles of the adaptors in the recruitment of their downstream substrates (Pawson, 1995) . Indeed, within the adaptor, the SH 2 and phosphotyrosine binding (PTB) domains bind to speci®c phosphotyrosyl peptide sequences, while the SH 3 domains interact constitutively with small prolinerich peptide motifs (Cohen et al., 1995; Kavanaugh and Williams, 1994; Koch et al., 1991; Songyang et al., 1993) . By this way, Shc, Crk and Nck may link the Ret TK to downstream cellular partners. Therefore, a further step in the characterization of the MEN 2B Ret-ptc 2 speci®c pathway, was obtained by comparing the pattern of the phosphoproteins interacting with these molecular adaptors in WT and 2B cell lysates. Analysis of the phosphoproteins coprecipitated with Shc failed to reveal any other phosphoprotein than Ret-ptc 2 (data not shown). In contrast, Crk and Nck which interacted equally with WT and MEN 2B Retptc 2 forms, also coimmunoprecipitated with several tyrosine phosphorylated proteins in 2B but not in WT lysates. It is worth noting that the Crk and Nck interacting phosphoproteins corresponded, by their sizes, to most of the cellular substrates dierentially phosphorylated in MEN 2B Ret-ptc 2 expressing cells.
The Crk associated phosphoproteins in 2B lysates, include two major phosphorylated bands of p68 and *p50 and minor unidenti®ed molecules with apparent molecular masses of 60, 120 and 200 kDa. Cytoplasmic phosphorylated proteins that interact with the Crk SH 2 domain were ®rst identi®ed in cells transformed by the v-Src or v-Crk oncogenes and include p130 Cas , p120
Cbl , p68 paxillin and Shc Sakai et al., 1994; Torres and Bogenmann, 1996) . However, the Crk associated *p50 was not recognized by a Shc antibodies (data not shown). In contrast, the interaction between Crk and Paxillin, in the MEN 2B Ret-ptc 2 expressing cells, could be directly demonstrated using the Crk SH 2 domain, thus indicating that it was dependent on Paxillin tyrosine phosphorylation. Accordingly, Paxillin was highly phosphorylated in response to the expression of MEN 2B mutated Retptc 2. Previous ®ndings demonstrated that phosphorylation of Paxillin was involved in the WT Ret Lysates from untransfected and WT, H13, 2B RET-PTC 2 transfected cells were precipitated with a Nck antibodies (Santa Cruz Biotechnology or UBI; lanes 1 ± 4), the Nck SH 2 (under native, lanes 5 ± 8 or denaturing conditions, lanes 9 ± 12), or SH 3 (lanes 13 ± 16) GST fusion proteins. Nck expression as well as precipitations of Ret-ptc 2 and tyrosine-phosphorylated proteins were analysed by sequentially probing the same blots with a Nck (data not shown), a Ret and a Ptyr antibodies (results obtained with P18 lysates were identical to WT and were not shown). Open and closed arrowheads represent the two isoforms of Ret-ptc 2 and the phosphorylated proteins, respectively transduction pathway (Romano et al., 1994) . However, in our analysis, only a weak Paxillin phosphorylation was detectable in WT lysates. This discrepancy may be due to the use of the constitutive activated Ret-ptc 2 form instead of the previous transient inducible Epidermal Growth Factor Receptor/Ret (EGFR/Ret) chimera. Indeed, long term treatment of PC12 cells with EGF declined the induced Paxillin tyrosine phosphorylation to the basal level (Hempstead et al., 1994) . Moreover, despite repeated eorts, we failed to detect Paxillin in a Crk precipitates, or inversely Crk in a Paxillin precipitates. Coimmunoprecipitation of p68 phosphoprotein with Crk suggest that such association does exist but is below the limit of detection. Dierence between our in vitro and in vivo experiments is probably due to the higher concentration of Crk GST than endogenous Crk used. Consistent with this possibility, Paxillin has never been detected in a Crk immunoprecipitates from dierent cellular models (Schaller and Parsons, 1995) . The Paxillin immunoprecipitates from 2B lysates contained a phosphoprotein of 50 kDa which exhibited the same SDS ± PAGE mobility as the *p50 coprecipitating with Crk. Furthermore, in vitro binding experiments under native and denaturing conditions indicated that Crk interacted directly through its SH 2 domain with both Ret-ptc 2 and Paxillin but not with the p50. Therefore, the presence of the phosphoprotein p50 in Crk immunoprecipitates is likely due to its association with Paxillin. On the basis of its molecular mass and its ability to interact with speci®c phosphorylation site on Paxillin through its SH 2 domain (Sabe et al., 1994) , the TK p50 Csk appears as a potential candidate. Nevertheless, the Crk associated p50 was not recognized by a Csk antibodies following Western blotting (data not shown), suggesting either that the amount of p50
Csk coprecipitated with Crk was under the limit of detection or that p50 corresponds to a still uncharacterized protein.
The Nck protein is closely related in structure to the Crk adaptor. However, it is currently unclear whether these two molecules play dierent roles in intracellular signal transduction or whether they are redundant in their function. Its function probably relies on its ability to bind speci®c proteins via its SH 2 and SH 3 domains. However, compared to Crk, little is known about its cellular targets. In addition to Retptc 2, we have shown that Nck interacted with at least eight phosphoproteins of respectively *50 ± 56, 63, 68, 130, 150 and 205 kDa in the MEN 2B but not in the WT Ret-ptc 2 expressing cells. The recruitment of these phosphoproteins may be achieved by direct interaction with the Nck SH 2 and/or SH 3 domains or the formation of a multicomponent complex. Since most of the Nck SH 2 precipitated proteins were lost when the lysates were denatured, one can assume that one or more proteins directly precipitated by the Nck SH 2 or SH 3 , could behave as a scaolding protein bringing the other signalling molecules. The presence of *p120 phosphoproteins directly interacting with Nck in MEN 2B Ret-ptc 2 expressing cells, prompted us to envisage that the docking proteins such as p130 Cas or p120
Cbl could be possible candidates. Indeed, both p130
Cas and p120 Cbl bind to Nck through its SH 2 and SH 3 domains respectively (Rivero-Lezcano et al., 1994; Vuori et al., 1996) and became weakly phosphorylated in MEN 2B Ret-ptc 2 expressing cells. However, immunodepletion of p130
Cas and p120 Cbl did not aect the pattern of the Nck associated phosphoproteins (data not shown).
The mechanisms by which the expression of the MEN 2B Ret-ptc2 elicited the tyrosine phosphorylation of these proteins remain to be elucidated. They may be direct, speci®c substrates for MEN 2B but not for the WT activated Ret TK. Accordingly, it has been proposed that the MEN 2B mutation changes the Ret TK substrate speci®city by substituting the Met 918 , a residue highly conserved in the transmembrane RTK to a Thr residue that is characteristic of cytosolic nonreceptor TK family (Hanks et al., 1988) . Consistently, when the MEN 2B mutation was introduced into the RET or EGFR sequences, their speci®city, as measured on synthetic substrates, switched to that characteristic of cytosolic Src-like kinases (Pandit et al., 1996; Songyang et al., 1995) . Our data support the idea that the MEN 2B mutation is sucient to orientate the kinase activity towards substrates that selectively interact with Nck and Crk. Furthermore, due to the nature of the RET-PTC 2 constructs used in this study, one can conclude that all the information necessary for the change in the TK speci®city and hence for the MEN 2B Ret oncogenic activity only resides in the mutated kinase domain. Nevertheless, we cannot exclude that a downstream protein TK speci®cally activated in MEN 2B Ret-ptc 2 expressing cells may phosphorylate these proteins.
The complex pattern of phosphoproteins coprecipitated by Nck and Crk suggest that these two adaptors may play important functions in the MEN 2B Ret signalling pathways. However, since they precipitated clearly distinct patterns of phosphoproteins, we believe that their functions may be dierent. Our study provides a basis for the identi®cation of downstream elements that bind Nck and Crk. Moreover, the ®nding that Paxillin is highly tyrosine phosphorylated in MEN 2B but not in WT Ret-ptc 2 expressing cells points to the possibility that MEN 2B transformation could modify the structure and signal transduction capacity of various components of the cytoskeleton. Further studies to address this question are in progress. This will be of crucial importance to better understand the MEN 2B Ret mediated cellular transformation process.
Materials and methods
Plasmids
The site-directed mutagenesis of the RET-PTC 2 cDNA has been previously reported as well as the cloning of each mutant cDNA (P18, H13, 2B) in pRc/CMV expression vector (Invitrogen) .
Cell culture and transfection COS 7 cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM, Gibco BRL) supplemented with 10% fetal calf serum (Gibco BRL), 2 mM L-Glutamine, 100 U/ ml penicillin and 100 mg/ml streptomycin. 100 mm diameter plates of COS 7 cells were transiently transfected with 4 mg of plasmid DNA following the DEAE-dextran (Pharmacia) method, as previously described (Seed and Aruo, 1987) . After a 48 h incubation, transfected and control cells were washed with phosphate-buered saline (PBS) and solubilized with lysis buer (50 mM Tris HCl pH 7.5, 150 mM NaCl, 1% Nonidet P 40 (NP40), 1 mM Na 3 VO 4 , 2 mM EDTA, 1 mM Aprotinin, 25 mM Leupeptin, 1 mM Pepstatin, 2 mM phenylmethylsulfonyl uoride (PMSF) for 30 min at 48C. Where indicated, transfected and control cells were serum starved for 20 h in fresh DMEM supplemented with 0.1% of Bovine Serum Albumin (BSA, Sigma). The expression of Ret-ptc 2 proteins was assessed by Western blotting using anti Ret antibody (a Ret C19, Santa Cruz Biotechnology).
In vitro binding assays
The cDNA coding for the SH 2 domains of PLCg (N+C), Crk, Nck, for the SH 3 domains of Crk and Nck and for the full-length proteins (Shc, Grb-2, Crk and Nck) was cloned into pGEX expression vector (Pharmacia) containing an in frame Glutathione-S Transferase (GST) tag. Puri®cation of the bacterially expressed GST recombinant proteins was performed as previously described (Ramos-Morales et al., 1994) and glutathione was removed by dialysis against PBS. Total proteins (600 mg) from transfected and control cell lysates were incubated with 5 mg of each GST fusion protein immobilized on Glutathione-Sepharose beads (Pharmacia) for 2 h at 48C. Pellets were then extensively washed as previously described (Ramos-Morales et al., 1994) and boiled in reduced Laemmli buer (Laemmli, 1970) . The complexes were analysed by Western blotting with a Ret and biotin conjugated a Ptyr antibodies. Where indicated, in order to assess whether the observed interactions were direct, lysates from control and transfected cells were heated at 958C for 5 min in the presence of 1% SDS and diluted to the ®nal SDS concentration of 0.1%. In vitro binding assay in the presence of dierent GST SH 2 fusion proteins was then performed, as already described.
Immunoprecipitation
Equal amounts of precleared whole extracts (1 ± 2 mg) from control and transfected cells were incubated with 2 ± 4 mg of the indicated antibodies for 12 h at 48C. The immunocomplexes were precipitated by incubation with protein A-Sepharose (Pharmacia) for 1 h at 48C. Immunopellets were washed four times in PBS 0.5% NP 40, once in PBS, then eluted with 40 ml of reduced Laemmli buer at 1008C for 5 min and resolved onto a 10% SDS ± PAGE.
Western blotting
Whole cell lysates or immunoprecipitates were separated on 10% SDS ± PAGE and electroblotted onto a polyvinylidene¯uoride membrane (PVDF Immobilon-P, Millipore) for 3 h at 48C in 20 mM Tris, 150 mM Glycine, 20% methanol (TE 62X Transphor II Unit, Hoefer). The blot was saturated in TNB buer (10 mM Tris HCl pH 7.4, 0.15 M NaCl, 1 mM EDTA, 0.1% Tween 20, 3% BSA, 0.5% gelatin) and then incubated overnight at 48C with either rabbit a Ret (50 ng/ml) or biotinylated antiphosphotyrosine (a Ptyr, Upstate Biotechnology Incorporated, UBI 0.25 mg/ml) or the indicated monoclonal or polyclonal speci®c antibodies. After three washes with TNN (10 mM Tris HCl pH 7.4, 0.15 M NaCl, 1% NP 40), the presence of primary polyclonal, monoclonal and biotinylated antibodies were revealed with Horseradish Peroxidase conjugated-a-rabbit (1:10 000, Dako),-a-mouse (1:7000, Sigma) or -biotin-streptavidin complex (1:10 000, Amersham) respectively and visualized by Enhanced Chemiluminescence detection system (ECL, Amersham). Where indicated, the immunoblots were stripped by 30 min incubation at 508C in 67 mM Tris HCl pH 6.7, 2% SDS, 100 mM b mercaptoethanol and reprobed following the protocol described above.
